iRay Group (SHA:688301)
China · Delayed Price · Currency is CNY 78.27
+1.39 (1.81%)
Oct 28, 2026, 9:45 AM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 24.52 billion as of October 27, 2026. It is the 4,437th most valuable company in the world and the 653rd biggest in China. Its market cap has increased by 1.35% in one year.
Market Cap
24.52B
Enterprise Value
24.86B
Revenue
2.86B
Global Rank
Country Rank
#653 China
PE Ratio
32.52
ChartMarket Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 24.52B, an increase of 111.11%. That is a compound annual growth rate of 13.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 24.52B | 14.82% |
| Dec 31, 2025 | 21.35B | 56.38% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gan & Lee Pharmaceuticals. | 41.79B |
| Imeik Technology Development | 30.66B |
| Intco Medical Technology | 27.85B |
| Andon Health | 22.53B |
| Zhende Medical | 21.19B |
| Winner Medical | 17.64B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.54B |
| Shenyang Xingqi Pharmaceutical | 12.14B |